Navigation Links
Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims

Activists, medical experts and counselors have urged the Ontario Government to launch a programme to ensure provision of drug treatment// to all victims of sexual assault, who might have been exposed to the HIV/AIDS virus. // The cost associated with this drug treatment ($1,200) has resulted in a limited availability of this therapy (combination therapy using Combivir and Kaletra).

Very little effort is being done to promote the availability of this potential life saving therapy amongst the general public, according to Llewellyn Goddard, an active member of the Toronto's People with AIDS Foundation. "There are gaps in terms of health campaigns out there and PEP (post-exposure prophylaxis) is one of them", said Watchorn, one of the health officials.

This form of treatment has been offered to health care workers since 1990. The pressure exerted by sexual assault centers and members of the medical community ensured availability of the treatment at more than 24 regional sex assault centers. In order for the treatment to be effective, it has to be offered within 72 hours of the incident.

This however would not have been possible if not for the joint study conducted by the Ontario Women's Health Council and the Centre for Research in Women's Health. It is further hoped that this facility can be made available to all sexual assault victims if it were to be funded universally.

The treatment, commonly known as morning-after pill for exposure to HIV, should be used in cases of known HIV exposure for a period of 28 days. If this information is not known, offering the treatment is largely based on the discretion of the attending physician. While doing so, it is equally important for the doctor to assess the risk associated with an encounter and to discuss the advantages and disadvantages with the patient, thereby enabling them take an informed decision.

If instituted within the stipulated time, has been f
'"/>




Page: 1 2

Related medicine news :

1. Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death
2. Birds Flu Scare Reaches Germany
3. LASIK Treatments Still To Reach Common Man
4. Number Of Bird Flu Cases In Switzerland Reaches 11
5. Cholera Death Toll Reaches 1,156 in Angola
6. Indonesia’s Bird Flu Death Toll Reaches 3
7. Growth Factors Help Neurons to Reach Their Correct Destination
8. Subsidies For GPs Visits : Agreement Reached
9. Latest Drug for AMD, Beyond The Reach Of Common Man
10. Medical Course in Kerala is Beyond the Reach of NRIs
11. Indonesias Bird Flu Death Toll Reaches 42

Post Your Comments:
(Date:11/26/2009)...pper sequestering drug tetrathiomolybdate (TM) has...tment of Wilson disease, a disease caused by an ov...That much is known. Very little, however, is known..., A new study led by Northwestern University res...three-dimensional structure of TM bound to copper-...
(Date:11/26/2009)... Dr. David Kim of the Live Life A...ery in Dallas , is one of a growing number of phys... networking sites to connect with individuals who ...o fight morbid obesity. Dr. Kim is utilizing Faceb...on about his practice with the community. , ...
(Date:11/25/2009)...EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmos...utachiropractorcanalsogivepatientsthehelptheyneed....reyourjaw(mandible)contacts/connectswithyourskull(...edwithTMJdysfunctionarepainwithchewing,clickingorp...TMJdysfunctionincluding:headaches,fatigue,sleepdis...
(Date:11/25/2009)...TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,a...alizationsoftwarelaunchesasuiteofnewleadingedgecli...areplatformatthisyear,sRadiologicalSocietyofNorthA...09(Booth5800,HallA).Theapplicationsleveragetheuniq...zedMRIimagingcoilsandsupportmultipleimagingmodalit...
(Date:11/25/2009)...SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQual...ter Spare the Air Alert forThursday,...relogsoranyothersolidfuel,bothindoorsandoutdoors. ...irqualitytomorrow,"saidJackBroadbent,executiveoffi...respectthehealthoftheirneighborsandfellowcommunity...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...Journal study finds natural, less expensive treatm...fferers , , PRINCETON, N.J., Dec. 2 With its... season is, for most, anticipated with excitement....rassing and debilitating gastrointestinal attacks,...
... PA. Patients treated with radiation prior to su...ces of cancer recurrence and better overall surviv..., The report examined a treatment called neoadjuv...chemotherapy and/or radiation. , Neoadjuvant the...
... Findings published in the December 1, 2008, issue...merican Association for Cancer Research, show lapa...cer, while women with HER2-negative breast cancer ...percent prevents some people from receiving optima...
... Dec. 2 /PRNewswire-FirstCall/ - NUCRYST Pharmaceu...cal products that fight infection and inflammation...received from its majority shareholder, The Westai...reholders. This equates to a return of capital of ...
... 2 Today Pascal Metrics Inc.,publicly announces i...agement,services for hospitals and healthcare syst...pidly has become a worldwide leader for clients se...safer from,medical failure and errors. , Acc...
...Barotz Dental is now one of only two dental,practi...ew Attachment,Procedure). This is the only laser ...proved for new attachment of gum and bone tissue a...nd discomfort to the,patient, closes the periodont...
Other Medicine News:Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Barotz Dental Now Offering Laser Gum Therapy 2
(Date:11/25/2009)...,, PRINCETON,N.J.,Nov.25/PRNewswire-FirstCal...harmaceuticalcompanycommittedtodiscovering,develop...ons,reportedfinancialresultsforthefiscalyearendedS...8.4millionincash,cashequivalentsandshortterminvest..., RG7128 ,, Phase2bTrial ,, InlateNov...
(Date:11/25/2009)...,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-Firs...cans,especiallythe27millionlivingwithuntreated hea...ologistCindyBeyer. ,, Dr.Beyer,seniorvicepresid...ingcareand hearingaids companies,saidstudieshaveli...tion,"whichcaneasilybeintensifiedatholidaygatherin...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12UCLA cancer researchers develop model that may help identify cancer stem cells 8850 1UCLA cancer researchers develop model that may help identify cancer stem cells 8850 2UCLA cancer researchers develop model that may help identify cancer stem cells 8850 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 1Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 1CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 2CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 3CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 5
...sented at the 2008 iSBTc Annual Meeting -, - Conf... discuss,results -, BRANFORD, Conn., Nov. 3 Cura...reliminary data from an ongoing Phase II,trial of ...ets GPNMB, for,the treatment of patients with unre...ck Hwu, Co-Principal Investigator, and Professor a...
...cent of patients achieve undetectable viral load i...ment with standard of care, SAN FRANCISCO, Nov. 1...435, an investigational protease inhibitor (PI) be... chronic hepatitis C virus,(HCV) infection. Tibote...including a late-breaker poster on the proof-of-pr...
Other Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: